blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1092770

EP1092770 - Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.09.2013
Database last updated on 19.10.2024
Most recent event   Tooltip06.09.2013Application deemed to be withdrawnpublished on 09.10.2013  [2013/41]
Applicant(s)For all designated states
THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of Technology Transfer, Suite 325, 6011 Executive Boulevard
Rockville, MD 20852-3804 / US
[N/P]
Former [2001/16]For all designated states
THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of Technology Transfer, Suite 325, 6011 Executive Boulevard
Rockville, MD 20852-3804 / US
Inventor(s)01 / Wang, Rong-Fu
5023 Jackwood Street
Houston, TX 77096 / US
02 / Rosenberg, Steven A.
10104 Iron Gate Road
Potomac, MD 20854 / US
 [2001/26]
Former [2001/16]01 / Wang, Rong-Fu
4949 Battery Lane No.409
Bethesda, MD 20814 / US
02 / Rosenberg, Steven A.
10104 Iron Gate Road
Potomac, MD 20854 / US
Representative(s)Schnappauf, Georg, et al
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
[N/P]
Former [2006/10]Schnappauf, Georg, et al
Dr. Volker Vossius Patent- und Rechtsanwaltskanzlei Geibelstrasse 6
81679 München / DE
Former [2001/16]Grund, Martin, Dr., et al
Dr. Volker Vossius Patentanwaltskanzlei Holbeinstrasse 5
81679 München / DE
Application number, filing date00125685.806.02.1997
[2001/16]
Priority number, dateUS1996059960209.02.1996         Original published format: US 599602
US1996072573604.10.1996         Original published format: US 725736
[2001/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1092770
Date:18.04.2001
Language:EN
[2001/16]
Type: A3 Search report 
No.:EP1092770
Date:04.06.2003
[2003/23]
Search report(s)(Supplementary) European search report - dispatched on:EP25.04.2003
ClassificationIPC:C12N15/12, C07K14/705, A61K38/17, A61P35/00, A61K48/00, C12N15/11, C07K16/30, C12Q1/68, G01N33/574, G01N33/50, A01K67/027
[2001/16]
CPC:
C12N9/0059 (EP,US); A61K2239/31 (EP,US); A61K2239/38 (EP,US);
A61K2239/57 (EP,US); A61K39/46 (EP,US); A61K39/4611 (EP,US);
A61K39/46449 (EP,US); A61P35/00 (EP); A61P37/04 (EP);
C07K14/4748 (EP,US); C12N9/0071 (EP,US); C12N9/90 (EP,US);
A01K2217/05 (EP,US); A61K2039/51 (EP,US); A61K38/00 (EP,US);
A61K39/00 (EP,US); A61K48/00 (EP,US); C12N2799/021 (EP,US);
G01N2474/20 (EP,US); Y10S435/975 (EP,US); Y10S530/828 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/16]
TitleGerman:Menschlicher Krebsagent des Tyrosinase ähnlichen Proteins 1 und 2 und Gene, die für sie kodieren[2001/16]
English:Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same[2001/16]
French:Antigène du cancer humain de protéine 1 et 2 apparentée à la tyrosinase et gènes le codant[2001/16]
Examination procedure23.11.2000Examination requested  [2001/16]
26.07.2006Despatch of a communication from the examining division (Time limit: M04)
17.11.2006Reply to a communication from the examining division
30.11.2007Despatch of a communication from the examining division (Time limit: M06)
29.05.2008Reply to a communication from the examining division
24.06.2008Despatch of a communication from the examining division (Time limit: M04)
14.10.2008Reply to a communication from the examining division
19.10.2009Despatch of a communication from the examining division (Time limit: M04)
24.02.2010Reply to a communication from the examining division
11.05.2011Despatch of a communication from the examining division (Time limit: M04)
12.09.2011Reply to a communication from the examining division
05.12.2012Despatch of a communication from the examining division (Time limit: M04)
16.04.2013Application deemed to be withdrawn, date of legal effect  [2013/41]
23.05.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/41]
Parent application(s)   TooltipEP97907609.8  / EP0882130
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19970907609) is  23.04.1999
Fees paidRenewal fee
23.11.2000Renewal fee patent year 03
23.11.2000Renewal fee patent year 04
22.01.2001Renewal fee patent year 05
25.02.2002Renewal fee patent year 06
25.02.2003Renewal fee patent year 07
23.02.2004Renewal fee patent year 08
22.02.2005Renewal fee patent year 09
27.02.2006Renewal fee patent year 10
27.02.2007Renewal fee patent year 11
25.02.2008Renewal fee patent year 12
26.02.2009Renewal fee patent year 13
24.02.2010Renewal fee patent year 14
23.02.2011Renewal fee patent year 15
24.02.2012Renewal fee patent year 16
Penalty fee
Additional fee for renewal fee
28.02.201317   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9114775  (SLOAN KETTERING INST CANCER [US]);
 [A]WO9523814  (NAT JEWISH CT IMMUN & RESPIRAT [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.